C

Concord Biotech Ltd

PharmaceuticalsSmallcap

About the company

Concord Biotech Limited, a biopharma company, engages in R&D, manufacturing, and marketing of pharmaceutical products in diverse therapeutic segments.

Live Performance

Current value of ₹ 100 invested once on Aug 18, 2023 would be
Stock
Loading Stock value

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 6 analysts offering recommendations for Concord Biotech Ltd

67%

Buy

33%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio37.6136.57
PB Ratio7.715.79
Dividend Yield0.80%0.59%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions